MFS Meridian Funds Blended Research European Equity A1 EUR

Reference Data

ISIN LU0648597655
Valor Number 13354335
Bloomberg Global ID BBG00228Q756
Fund Name MFS Meridian Funds Blended Research European Equity A1 EUR
Fund Provider MFS International Limited London, United Kingdom
Phone: +44 20 7429 7200
Fund Provider MFS International Limited
Representative in Switzerland Reyl & Cie S.A.
Genève
Phone: +41 22 816 80 00
Distributor(s) Carnegie Fund Services S.A.
Genève 11
Phone: +41 22 705 11 77
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Fund’s objective is capital appreciation, measured in Euros. The Fund invests primarily (at least 70%) in European equity securities. Some of the countries in Europe, primarily those in Eastern Europe, are currently considered emerging market economies. The Fund may invest in companies it believes to have above average earnings growth potential compared to other companies (growth companies), in companies it believes are undervalued compared to their perceived worth (value companies), or in a combination of growth and value companies. The Fund generally focuses its investments in larger companies, but may invest in companies of any size. The Fund may invest a relatively large percentage of its assets in a small number of countries and/or a particular geographic region.
Peculiarities

Fund Prices

Current Price * 32.99 EUR 03.04.2025
Previous Price * 33.91 EUR 02.04.2025
52 Week High * 35.11 EUR 28.02.2025
52 Week Low * 30.04 EUR 05.08.2024
NAV * 32.99 EUR 03.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 149,666,629
Unit/Share Assets *** 2,824,299
Trading Information SIX

Performance

YTD Performance +4.50% 31.12.2024
03.04.2025
YTD Performance (in CHF) +6.20% 31.12.2024
03.04.2025
1 month -5.93% 03.03.2025
03.04.2025
3 months +4.07% 03.01.2025
03.04.2025
6 months +3.38% 03.10.2024
03.04.2025
1 year +6.80% 03.04.2024
03.04.2025
2 years +21.11% 03.04.2023
03.04.2025
3 years +19.79% 04.04.2022
03.04.2025
5 years +80.87% 06.04.2020
03.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Roche Holding AG 3.32%
ASML Holding NV 3.12%
Nestle SA 3.10%
Novo Nordisk AS Class B 2.75%
Schneider Electric SE 2.33%
UBS Group AG 2.23%
Sanofi SA 2.22%
Banco Santander SA 2.11%
Rolls-Royce Holdings PLC 2.07%
Zurich Insurance Group AG 1.96%
Last data update 28.02.2025

Cost / Risk

TER *** 0.25%
TER date *** 31.07.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.60%
Ongoing Charges *** 1.60%
SRRI ***
SRRI date *** 28.02.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)